Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Chronic kidney disease in gout in a managed care setting

  • Mahesh J Fuldeore1,
  • Aylin A Riedel2,
  • Victoria Zarotsky3Email author,
  • Bhavik J Pandya4,
  • Omar Dabbous4 and
  • Eswar Krishnan5
BMC Nephrology201112:36

DOI: 10.1186/1471-2369-12-36

Received: 9 September 2010

Accepted: 3 August 2011

Published: 3 August 2011

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
9 Sep 2010 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
9 Sep 2010 Author responded Author comments - Bhavik Pandya
Resubmission - Version 4
9 Sep 2010 Submitted Manuscript version 4
9 Nov 2010 Reviewed Reviewer Report - William McCLellan
3 Apr 2011 Reviewed Reviewer Report - David Mount
20 May 2011 Author responded Author comments - Bhavik Pandya
Resubmission - Version 5
20 May 2011 Submitted Manuscript version 5
22 Jun 2011 Reviewed Reviewer Report - David Mount
27 Jun 2011 Reviewed Reviewer Report - William McCLellan
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
3 Aug 2011 Editorially accepted
3 Aug 2011 Article published 10.1186/1471-2369-12-36

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Abbott Laboratories, Health Economics & Outcomes Research, Formerly at TAP Pharmaceutical Products Inc., now part of Takeda Pharmaceuticals International Inc
(2)
OptumInsight, Health Economics & Outcomes Research
(3)
OptumInsight, Clinical Services
(4)
Takeda Pharmaceuticals International, Inc., Global Health Economics Outcomes Research
(5)
Stanford University Medical School, Division of Immunology and Rheumatology

Advertisement